U.S. market Open. Closes in 5 hours 19 minutes

ABBV | AbbVie Inc. Stock Overview

(Stock Exchange: NYSE)
Day's Range 204.61 - 210.81
52 Week Range 153.58 - 218.66
Beta 0.54
Implied Volatility 31.03%
IV Rank 83.87%
Day's Volume 11,079,762
Average Volume 6,329,994
Shares Outstanding 1,768,980,000
Market Cap 370,636,689,600
Sector Healthcare
Industry Drug Manufacturers - General
IPO Date 2013-01-02
Valuation
Profitability
Growth
Health
P/E Ratio 88.03
Forward P/E Ratio 15.36
EPS 2.38
1YR Price Target 175.00
Dividend Yield 3.20%
Dividend Per Share 4.28
Dividend ExDate 2024-01-12
Dividend PayDate 2024-02-15
Employees 50,000
Country USA
Website ABBV
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira, administered via injection.
ABBV's peers: MRK, PFE, LLY, BMY, JNJ, AMGN, GILD, ABT, AMRN, AZN, BIIB, GSK, NVS, OGN, SNY, SCLX
*Chart delayed
Analyzing fundamentals for ABBV we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is moderate, Growth is exceptionally good and Health is very weak. For more detailed analysis please see ABBV Fundamentals page.

Watching at ABBV technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on ABBV Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙